Site: CDL-Atlanta, CDL-Toronto
Stream: Health, Recovery
Dawn Bell is Global Development Head, Strategic Partnerships Team for Novartis. In this role, she works closely with internal and external stakeholders across the Novartis portfolio to explore disruptive whitespace opportunities. Prior to this role, Dawn served as Chief Scientific Officer, Novartis Canada where she oversaw the Pharma portfolio and co-founded the Montreal Biome at Mila. Dawn has deep knowledge of drug development, reimbursement and commercialization, and has developed and launched more than a dozen innovative medicines. She has a passion for entrepreneurship and start-up communities and is a sought after mentor for start-ups in North America and Europe through her work at CDL and EIT Health’s Gold Track Program. She was Associate of the Year for CDL-Toronto in 2019. She earned her Doctor of Pharmacy degree from the University of Florida and was a tenured professor at West Virginia University before joining industry.